Completed
A Phase II Study of Bermekimab (MABp1) in Patients With Moderate to Severe Atopic Dermatitis
NCT03496974
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- Florida Academic Centers Research & Education Coral Gables, Florida, United States